Akil Merchant

Cedars-Sinai Medical Center

NIH Rank #6012
  • Program Leader
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.9M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#6,012
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.9M across 3 grants · National rank #6012.

Top grants by award amount

Akil Merchant's NIH grant portfolio, ranked by award amount.

  • 3U54CA260591-02S4U54
    Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2
    $989.3K
    award amount
  • 5R01CA266544-03R01
    Spatially resolved, single cell biomarkers of B cell lymphoma
    $768.1K
    award amount
  • 3R01CA266544-02S1R01
    Generation of novel murine B-cell lymphoma models using mosaic analysis by dual recombinase-mediated cassette exchange (MADR) to more closely resemble human B-cell lymphomas
    $118.9K
    award amount

Affiliation

Institutions that have administered grants for Akil Merchant.

Affiliated with Cedars-Sinai Medical Center (CA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Cedars-Sinai Medical Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6012